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AS any good high school student can tell you, normal 
developmental processes give rise to individuals in 
which each cell contains an identical copy of the genome 
present in the original, fertilized egg. This comfortable 
image of a static and inviolate genetic blueprint was 
shattered in the late 1970s, however, when Susumu To- 
negawa and colleagues showed that the genes that en- 
code immunoglobulin heavy and light chains have a 
different structure in embryonic cells from that found in 
tumors derived from B cells (see accompanying Com- 
mentary by Tonegawa, 2004). Over the next decade, it 
would emerge that developing B lymphocytes assemble 
immunoglobulin genes from widely scattered gene seg- 
ments, using a somatic DNA rearrangement process 
known as V(D)J recombination (Figure 1), and that devel- 
oping T cells play the same trick to assemble functional 
T cell receptor genes. 
The discovery of a new process, such as V(D)J recom- 
bination, challenges us to transform the phenomenology 
of the molecular genetics into mechanistic, biochemical 
understanding. We could easily guess that V(D)J recom- 
bination was catalyzed by a "recombinase" enzymatic 
machinery, but what were the components of this ma- 
chine, how did it work, and what were its evolutionary or- 
igins? 
There was no lack of interest in finding the V(D)J re- 
combinase. Throughout the 1980s, the primary ap- 
proach taken was that of traditional biochemistry. Inves- 
tigators sought (and found, and published) a variety of 
intriguing, but ultimately disappointing, nuclease and 
DNA binding activities. Others attempted to reconstitute 
the entire reaction in cell-free, crude extracts, while yet 
others took a molecular approach, using subtractive 
hybridization to search for genes expressed specifically 
in cells with an active V(D)J recombination system. 
It was in early 1985, in this turbulent atmosphere of 
lofty and frustrated aspirations, that one of us (D.G.S.) 
began his graduate studies in the laboratory of the other 
(D.B.) in the Whitehead Institute at MIT. The ensuing 
effort to find the V(D)J recombinase was imbued with 
extraordinary good luck and the naivete and optimism 
of a graduate student who had yet to experience his 
first major setback. 
The first stroke of good fortune was that a previous 
graduate student in the lab, Susanna Lewis, had just 
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months before described a novel method of selecting for 
cells with the capability to perform V(D)J recombination 
(Lewis et al., 1984). Based on Lewis's concept, a retrovi- 
ral substrate was developed in which V(D)J recombina- 
tion would trigger inversion of a drug resistance gene, 
allowing cells with recombination activity to be selected 
for by their expression of drug resistance. As might be 
expected, the substrate underwent V(D)J recombination 
in a subset of lymphocyte cell lines, but not in non- 
lymphoid 3T3 fibroblasts (Schatz and Baltimore, 1988). 
When these results were presented at our weekly group 
meeting, Yoav Citri, a postdoctoral fellow, suggested 
that it would be interesting to explore methods for acti- 
vating V(D)J recombination in the 3T3 fibroblast cells 
harboring the recombination substrate. This pivotal sug- 
gestion changed the course of the research and that of 
several careers. 
Triggering V(D)J recombination in fibroblasts would 
almost certainly require these cells to express one or 
more lymphocyte-specific genes--the crucial phrase 
being "one or more." If just one gene were required, 
standard methodologies for complementation by gene 
transfer might succeed if the gene were reasonably 
sized; but if more than one gene were needed, such an 
approach would be little more than wishful thinking. 
And, given the complexities of the V(D)J recombination 
reaction, it did indeed seem fanciful to believe that a 
single novel gene could induce fibroblasts to perform 
this reaction. 
Nevertheless, a brave graduate student, over the con- 
servative advice of his paternalistic mentor, undertook 
the gene transfer/complementation approach. The stan- 
dard tool one would use now would be a cDNA expres- 
sion library prepared from immature lymphocytes. The 
cDNAs from such a library would be introduced into 3T3 
flbroblasts containing the recombination substrate, and 
the cells would then be selected for expression of the 
drug resistance gene. As became obvious after the fact, 
such an approach would never have succeeded be- 
cause, indeed, there were two proteins involved, RAG1 
and RAG2, and the chance of introducing two different 
cDNAs into the same cell is vanishingly small. Good 
fortune intervened, however, in that the methodology 
of genomic transfection was in extensive use in the 
neighboring laboratory of Robert Weinberg. In this 
method, genomic DNA (in the form of large [~100 kb] 
fragments) is transfected into a recipient cell line, and 
the transfectants are then analyzed for a new activity 
or property, in this case, the ability to perform V(D)J 
recombination. Surprisingly, when genomic DNA was 
transfected into fibroblasts containing the recombina- 
tion substrate, several clones were isolated that stably 
manifested the capacity to perform V(D)J recombination 
(Schatz and Baltimore, 1988). 
This result seemed to indicate that one gene (or, more 
accurately, one genomic locus) could trigger V(D)J re- 
combination in nonlymphoid cells. The challenge then 
became to find that gene (locus). This turned out to be 
nontrivial and might not have happened at all were it 
not for Marjorie Oettinger, a new graduate student who 
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Figure 1. V(D)J Recombination and Assem- 
bly of the Ig Heavy Chain Locus 
The Ig heavy chain locus i  assembled in two 
steps, beginning with joining of a D and a J 
gene segment, followed by joining of a V gene 
segment o DJ. The chromosomal regions be- 
tween D and J and between V and DJ are 
deleted from the chromosome, although in 
certain antigen receptor loci, some recombi- 
nation events occur by inversion. After V(D)J 
recombination, transcription initiates at a promoter upstream of V and the VDJ exon is spliced to the downstream CI~ constant region exons 
(which are depicted as a single rectangle for simplicity), allowing expression of the Ig i~ heavy chain polypeptide. Splicing can also occur to 
C~ exons to direct expression of Ig 8, or after class switch recombination (which deletes C~ and C5), C~,, C~, and Ctx exons can be utilized. 
threw her considerable energy, ideas, and wry wit into 
the effort. Although the butt of many jokes, the Tweedle- 
dee/Tweedledum team of Oettinger and Schatz was able 
to pursue several cloning strategies simultaneous, and 
perhaps more important, to maintain a sense of opti- 
mism in the face of results, and an atmosphere, that 
were often less than encouraging. This atmosphere is 
well illustrated by a comment made to D.G.S. in the 
summer of 1988 by a postdoctoral fellow in a nearby 
lab: "Oh, so you're the person who published that artifact 
in Cell" (referring to the activation of V(D)J recombination 
in fibroblasts; Schatz and Baltimore, 1988). To put it 
bluntly, many people were of the opinion that we were 
chasing a nonexistent phantom gene. 
In the face of this skepticism, the temptation was to 
resort to humor, and there was no shortage of this in 
room 317 of the Whitehead Institute. A memorable ex- 
ample took place one evening when the "early" member 
of the tag-team (Schatz, arrival at lab 7 am, departure 
7 pm) set up two capillary transfer Southern blots (his 
signature technique) and left for the day, turning things 
over to the "late" member of the team (Oettinger, arrival 
11 am, departure 11 pm on a good night). By early the 
next morning, the two Southern transfers had apparently 
given birth to a third; closer inspection revealed, how- 
ever, that the newcomer contained a peanut butter and 
jelly sandwich, instead of an agarose gel, nestled be- 
tween sponges, layers of Whatman paper, and paper 
towels. Not only were the results of this blot of dubious 
value, but there was the serious question of what Schatz 
would eat for lunch that day. 
The key challenge faced by Tweedledee and Tweedle- 
dum was to find the relevant gene (locus) amongst the 
morass of the genome. Of the numerous approaches 
taken, success came from the use of an oligonucleotide 
"tag" that was ligated to bulk genomic DNA and then 
used to trace the fate of transfected DNA through suc- 
cessive rounds of transfection and selection. Southern 
blotting with the oligonucleotide as probe revealed that 
the tag had become closely linked to the genetic locus 
of interest and could then be used as the starting point 
for a genomic "walk" to isolate the gene. 
This turned out to be far more difficult han expected. 
The first challenge ncountered was that fragments con- 
taining the oligonucleotide tag could not be found in 
multiple genomic libraries, and hence appeared to be 
unclonable. Only when a library was plated on a highly 
recombination-defective strain of bacteria was a single 
clone obtained. The genomic walk then began, but it 
moved forward with agonizing slowness because each 
step landed in a new, noncontiguous portion of the ge- 
home. Eventually, five different genomic libraries were 
required to allow these breakpoints to be spanned. The 
walk ended abruptly within a transcription unit whose 
mRNA had the satisfying property of being expressed 
in the appropriate lymphocyte cell lines and recombina- 
tionally active transfectants. The gene was cloned and 
named RAG1, the Recombination Activating Gene-1 
(Schatz et al., 1989). 
This might have been the end of the story but it was 
not, because the isolated gene was disturbingly ineffec- 
tive. We expected expression of the RAG 1 cDNA in fibro- 
blasts to result in very efficient activation of V(D)J recom- 
bination, but instead, the cDNA expression vector was 
no more efficient in activating recombination than was 
bulk genomic DNA. This observation led to several 
months of intense puzzlement, frantic experimentation, 
and thence to a number of wacky explanations for this 
unexpected result. One of the far-fetched ideas was that 
a second gene, closely linked to RAG1, was required 
for efficient activation of recombination. Wacky or not, 
a search for nearby transcription units rapidly led to the 
identification of RAG2, a gene that resided only a few 
kilobases away from RAG1 (Figure 2A; Oettinger et al., 
1990). Further experiments demonstrated that RAG1 
and RAG2 were almost invariably expressed together 
and that their coexpression resulted in the expected 
potent activation of V(D)J recombination (Oettinger et 
al., 1990). 
At this point in the story, both students left MIT with 
PhD degrees, jettisoned their plans to finish the medical 
degrees they had begun at Harvard, and each started 
his or her own laboratory. 
The discovery of RAG1 and RAG2 provided the impe- 
tus for significant advances in many directions: under- 
standing of the mechanism of V(D)J recombination, in- 
sights into lymphocyte development, a deepened 
understanding of mechanisms of DNA repair, and eluci- 
dation of the origin of certain human immunodeficien- 
cies. The first order of business was to determine the 
basic function of the RAG1 and RAG2 proteins: did they 
participate directly in V(D)J recombination or did they 
instead play an indirect role, activating other genes/ 
factors that were the direct players? Although it took 
five years, elegant biochemistry from the Gellert and 
Oettinger laboratories eventually demonstrated that 
RAG1 and RAG2 constitute the sequence-specific DNA 
endonuclease that initiates V(D)J recombination (McBlane 
et al., 1995; van Gent et al., 1995). Studies in a number 
of labs subsequently provided insight into how RAG1/ 
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Figure 2. The RAG Genomic Locus and Hy- 
pothetical RAG Transposon 
(A) The RAG genomic locus is remarkably 
compact. RAGI and RAG2 are nearest neigh- 
bors and convergently transcdbed (arrows) 
in all vertebrate species examined to ate. 
The genes are separated by 3-15 kb de- 
pending on the species, and the open reading 
frames (red rectangles) of both RAG1 and 
RAG2 are each contained in a single large 
exon in almost all species (including human 
and mouse). Dashed lines indicate splicing of 
5' untranslated exons to the main exon. 
(B) The hypothetical RAG transposon. It is 
plausible that 400-500 million years ago,at 
the time that jawed vertebrates first evolved, 
a transposable lement existed containing 
the RAG1 and RAG2 open reading frames 
(rectangles) flanked by recombination signal 
sequences (RSSs; triangles). Dashed arrows 
indicate the presumed irection of transcrip- 
tion of the genes. Derived from Thompson 
(1995). 
RAG2 bind and cleave DNA. Curiously, almost all dis- 
crete domains and activities identified to date reside 
within RAG1, while RAG2 remains an essential but 
largely enigmatic participant (Fugmann et al., 2000; van 
Gent et al., 1996). 
Within two years of the identification of these genes, 
mice deficient in either RAG1 or RAG2 were generated 
and found to exhibit a complete block in V(D)J recombi- 
nation (Mombaerts et al., 1992; Shinkai et al., 1992; 
Spanopoulou et al., 1994). Because lymphocyte devel- 
opment is dependent on successful assembly of antigen 
receptor genes, these mice exhibit a complete absence 
of mature B and T cells, making them ideal "empty" 
hosts into which lymphocyte populations or hematopoi- 
etic precursors can be transferred for in vivo analyses. 
In retrospect, it is clear that cloning of RAG1 and 
RAG2 by transfecting enomic DNA was successful only 
because the two genes lie so close to one another (Fig- 
ure 2A) and hence behaved as a single genetic locus in 
the assay. Was this merely a wildly unlikely, and lucky, 
occurrence, or is there some deeper significance to the 
fact that RAG1 and RAG2 are nearest neighbors and 
have a very compact organization? A satisfying answer 
to this question came with the discovery that RAG1 and 
RAG2 together constitute a transposase and catalyze a 
reaction with extensive mechanistic similarities to the 
well-studied bacterial transposases (Agrawal et al., 
1998; Hiom et al., 1998). Based on this and other find- 
ings, it is reasonable to think that, early in evolution, 
RAG1 and RAG2 existed as components of a transpos- 
able element (the "RAG transposon;" Figure 2B) that 
contained all of the information ecessary to jump from 
genome to genome and hence to propagate itself (Agra- 
wal et al., 1998; Thompson, 1995). This idea, if correct, 
has profound implications for the evolution of adaptive 
immunity. It has long been speculated that antigen re- 
ceptor genes came to be split into component gene 
segments when a transposon landed in an ancestral 
receptor gene and split it into two parts. The introduction 
of the RAG transposon into the germline of an early 
vertebrate ancestor could explain why all jawed verte- 
brates contain the RAG genes (immediately adjacent to 
one another), perform V(D)J recombination, and make 
use of an adaptive immune system made up of B and 
T lymphocytes, while no lower species examined thus 
far contains any trace of these entities. It is entirely 
possible that the existence of jawed vertebrates, which 
are highly vulnerable to infection, was dependent on 
the chance occurrence of an interspecies gene transfer 
providing the necessary wherewithal to counter infec- 
tions through the complicated but effective process of 
an adaptive immune system based on gene fragment 
recombination. We know that all lower species share 
with vertebrates many other mechanisms of countering 
microbial invasion (the mechanisms of innate immunity). 
But we also know that RAG-deficient mice (as well as 
humans, see below) are highly susceptible to bacterial 
and viral pathogens, indicating the critical importance 
of the adaptive immune system to vertebrates. 
Finally, recent studies have provided a clear link be- 
tween the RAG genes and human disease. Two distinct 
forms of severe combined immunodeficiency are 
caused by germline mutations that result in a partial or 
total inactivation of either RAG1 or RAG2 (Schwarz et 
al., 1996; Villa et al., 1998). In addition, there is growing 
evidence that errors made during the process of V(D)J 
recombination are the cause of chromosomal transloca- 
tions found in certain lymphoid tumors (Mills et al., 2003). 
Beginning then with Tonegawa's discovery that the 
vertebrate genome is not inviolate but is instead molded 
into an astonishing array of different configurations in 
each of us, we have moved to an appreciation of the 
enzymes that generate these configurations, and thence 
to a growing, but still incomplete, knowledge of the 
mechanisms by which they act. Major challenges for 
the future include determining the three-dimensional 
structure of the RAG proteins, both individually and in 
complex with DNA, understanding the dynamic changes 
that occur in the protein-protein and protein-DNA con- 
tacts during the course of the V(D)J recombination reac- 
tion, and unraveling the secrets of the nucleus and chro- 
matin structure that dictate the xquisite developmental 
regulation of antigen receptor gene assembly. 
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Summary 
Using a pCRI plasmid containing an enzymatically 
synthesized, full-length DNA transcript of immu- 
noglobulin k chain mRNA as the hybridization 
probe in the Southern gel blotting experiments 
(Southern, 1975), we identified three DNA frag- 
ments of 8.6, 4.8 and 3.5 kb in Eco RI-digested 
total DNA from BLAB/c mouse embryos. A fourth 
fragment of 7.4 kb was found in addition to these 
three fragments in similarly digested total DNA 
from a k chain-secreting myeloma (HOPC 2020). 
We have cloned the four DNA fragments in an EK- 
2 phage vector, kwEs, and characterized them with 
respect to size, type of ~ gene sequences con- 
tained and position of these sequences in the 
fragments, using agarose gel electrophoresis, 
the gel blotting technique and electron micro- 
scopic R loop mapping. The embryonic DNA 
clones Ig 99~, Ig 25~ and Ig 13,~ contain one copy 
each of V,~, C,~ and V~, sequences, respectively, 
while the myeloma DNA clone Ig 303~ contains 
one copy each of V~t and C~ sequences that are 
separated by a 1.2 kb nontranslated DNA seg- 
ment. Ig 25~ was also shown to contain a DNA 
segment of approximately 40 base pairs (bp) (J 
sequence) that lies 1.2 kb away from the C,~ 
sequence and is homologous to the V-C junction 
region of a ~ mRNA. Heteroduplex analysis of the 
three ~ DNA clones revealed that Ig 303k DNA is 
composed of two parts, one of which is entirely 
homologous to one end of Ig 99k, and the other to 
one end of Ig 25~ DNA. The sequence arrange- 
ment observed in the cloned DNA is the same as 
that in the corresponding cellular DNA. This was 
shown by identifying certain restriction enzyme 
cleavage sites on the cloned DNAs and demon- 
strating the presence of these sites in the total 
cellular DNA by the gel blotting technique. The 
site of the homology switch is at the boundary of 
the V sequence and the 1.2 kb nontranslated DNA 
segment, and corresponds to the position of the 
J sequence on the Ig 25k DNA. We consider the 
above experimental results the most direct evi- 
dence for somatic rearrangement in immuno- 
globulin genes. We discuss the significance of 
these findings for the origin of genes in the 
evolution of higher organisms and in cell differ- 
entiation. 
Introduction 
Are DNA sequences in the cells of higher orga- 
nisms rearranged during normal cell differentia- 
tion? The restriction enzyme mapping in mouse 
DNAs strongly suggested that this is the case in 
lymphocytes for the immunoglobulin genes. Very 
different patterns of hybridization were obtained 
when K light chain mRNA from a K chain-producing 
myeloma was hybridized with mouse embryo DNA 
or with homologous myeloma DNA, both of which 
had been digested with the restriction endonucle- 
ase Bam HI and fractionated by agarose gel elec- 
trophoresis (Hozumi and Tonegawa, 1976). 
Suggestive evidence for a similar DNA rearrange- 
ment involving ;~ chain genes was obtained when 
DNAs from embryo and from a k chain-producing 
myeloma were compared (Tonegawa et al., 1976). 
Furthermore, a pattern change was detected only 
for those immunoglobulin genes that are active in 
a given myeloma cell (Tonegawa et al., 1977a, 
1977b). These results indicated that in embryo 
cells, the DNA sequences coding for the amino 
terminal half (V region) and for the carboxy termi- 
nal half (C region) are separate, and that the two 
sequences are brought to proximity during the 
differentiation of B (bone marrow-derived) lympho- 
cytes. An alternative, improbable interpretation 
was also considered: the pattern difference might 
result from mutations or base modifications in the 
enzyme cleavage sites (Hozumi and Tonegawa 
1976). 
Two subtypes of mouse ;~ chains are known, ;~ 
and ~,, which are characterized by the specific C 
region sequences C~= and C~,. Amino acid se- 
quence studies have so far established seven dif- 
ferent Vxt regions and one V~, region (Weigert et 
al., 1970; Dugan et al., 1973). Statistical considera- 
tions suggest that the mouse is capable of synthesiz- 
ing many more than seven different V regions of 
the ;~ subtype (Tonegawa, 1978). The two k subtype 
chains each seem to be encoded in a pair of DNA 
segments, one for the V and the other for the C, 
that lie in separate sections of the embryo DNA. 
Restriction enzyme mapping of total cellular DNA 
combined with hybridization kinetics strongly sug- 
gested that there are no more than few copies (and 
there is probably only one copy) per haploid genome 
of the DNA segment encoding each of the four ;~ 
chain regions V×, C~, V~, V~, and Cx, (Tonegawa et 
al., 1976). Hence the multiple V×~ regions ob- 
served in myelomas must have been generated by 
a somatic process. 
To obtain more direct evidence for gene rear- 
rangement, we have isolated, by in vitro recombi- 
nation with phage k DNA, DNA fragments from 
both embryo and myeloma cells that carry part or 
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Summary 
The RAG-1 (recombination activating gene-1) genomic 
locus, which activates V(D)J recombination when in- 
troduced into NIH 31"3 fibroblasts, was isolated by 
serial genomic transfections of oligonucleofide-tag- 
ged DNA. A genomic walk spanning 55 kb yielded a 
RAG-1 genomic probe that detects a single 6.6-7.0 kb 
mRNA species in transfectants and pre-B and pre-T 
cells. RAG-1 genomic and cDNA clones were biologi- 
cally active when introduced into NIH 3T3 cells. 
Nucleotide sequencing of human and mouse RAG-1 
cDNA clones predicts 119 kd proteins of 1043 and 1040 
amino acids, respectively, with 90% sequence iden- 
tity. RAG-1 has been conserved between species that 
carry out V(D)J recombination, and its pattern of ex- 
pression correlates exactly with the pattern of expres- 
sion of V(D)J recombinase activity. RAG-1 may acti- 
vate V(D)J recombination indirectly, or it may encode 
the V(D)J recombinase itself. 
Introduction 
The enormous number of genes required to encode the 
subunits of the immunoglobulin (Ig) and T cell receptor 
(TCR) molecules of B and T cells are generated com- 
binatorially in a process known as V(D)J recombination, 
so called for the variable (V), diversity (D), and joining (J) 
gene segments used in the recombination process. V(D)J 
recombination is known to assemble seven different loci 
in developing lymphocytes: i~, K, and ;~ in B cells, and ~, 
13, ~, and 5 in T cells (for reviews see Blackwell and AIt, 
1988; Davis and Bjorkman, 1988; Raulet, 1989). The B 
and T cell lineages appear to share a common V(D)J 
recombinase (see below) whose expression is tightly 
regulated during development; recombination of endoge- 
nous loci or exogenously introduced substrates occurs 
only in cells representing the early stages of B and T cell 
development and does not occur in nonlymphoid cells 
(Lieber et al., 1987; Schatz and Baltimore, 1988). V(D)J 
recombination is also regulated at the level of substrate 
availability, since loci normally recombined in one cell 
type are never fully recombined in the other. In some in- 
stances, it has been possible to correlate the recombina- 
tion of a locus with its transcription and increased sensitiv- 
ity to DNAase I, suggesting that the "accessibility" of a 
locus to the recombinase may be modulated by its tran- 
scription (Yancopoulos and AIt, 1985; Blackwell et al., 
1986; Yancopoulos et al., 1986; Schlissel and Baltimore, 
1989). 
The cis-acting DNA sequences that are necessary and 
sufficient for V(D)J recombination consist of a palindromic 
heptamer and AT-rich nonamer separated by a spacer of 
either 12 or 23 bp (Tonegawa, 1983; Hesse et al., 1989). 
Spacer length defines two classes of such recombination 
signal sequences (RSSs); efficient recombination occurs 
only when one RSS of each class is involved (the "12-23 
joining rule"). RSSs lie directly adjacent to all recombina- 
tionally competent V, D, and J gene segments, and their 
sequences are conserved between the recombining loci 
and between all species known to carry out V(D)J recom- 
bination (Litman et al., 1985a, 1985b; Reynaud et al., 
1985; Schwager et al., 1988). RSSs from different loci and 
species appear to be functionally interchangeable be- 
cause they direct proper V(D)J recombination in a variety 
of host pre-B and pre-T cells (Yancopoulos et al., 1986; 
Bucchini et al., 1987; Goodhardt et al., 1987; Lieber et al., 
1987). The sequence conservation and functional equiva- 
lence of RSSs together provide strong evidence for a sin- 
gle, evolutionarily conserved V(D)J recombinase. 
Remarkably little is known, however, about the trans- 
acting factors that participate in V(D)J recombination; no 
factor has yet been demonstrated to be an essential com- 
ponent of the enzyme. V(D)J recombination could be ex- 
pected to require several distinct enzymatic activities: 
sequence-specific DNA recognition, endonucleolytic cleav- 
age between the RSS and gene segment, and ligation of 
the cleaved ends. In addition, because nucleotides are 
frequently lost and/or added at coding segment junctions, 
both exonucleolytic and DNA polymerase activities hould 
be associated with the recombinational machinery. It is 
not known how many factors participate in V(D)J recombi- 
nation, nor is it known how many are lymphoid specific. 
We will use the term V(D)J recombinase to refer only to 
the essential component(s) of the enzyme whose activity 
is restricted to recombinationally active B and T cells. 
Thus far, only the enzyme terminal deoxynucleotidyl trans- 
ferase (TdT) has been implicated in V(D)J recombination, 
where it is likely to add non-germline-encoded nucleo- 
tides (N regions) to the coding junction (Landau et al., 
1987). TdT is not, however, required for V(D)J recombina- 
tion. Some of the other activities expected to be associ- 
ated with the recombinase have been detected in nuclear 
extracts of lymphoid cells--heptamer binding (Aguilera 
et al., 1987), nonamer binding (Halligan and Desiderio, 
1987), and endonucleolytic cleavage (Desiderio and Balti- 
more, 1984; Hope et al., 1986; Kataoka et al., 1984)--but 
the relationship of these factors to V(D)J recombination re- 
mains unclear. Finally, a factor critical in V(D)J recombina- 
tion may be contributed by the gene that is disrupted in 
the severe combined immunodeficient (scid) mouse (Bos- 
ma et al., 1983), which is characterized primarily by a 
defect in recombination of Ig and TCR gene segments 
(Schuler et al., 1986). 
